The controlled-releasing drug implant based on the three dimensional printing technology: Fabrication and properties of drug releasing in vivo

Abstract

Three dimensional (3D) printing technology was utilized to fabricate a new type of drug implant with complicated architectures, employing levofloxacin (LVFX) and rifampicine (RFP) as model drugs. The prepared drug implant prototype consists of a double-layer structure, of which the upper region is a reservoir system containing RFP and the lower region is a matrix one containing LVFX. The release test in vivo revealed that LVFX was released in the early stage; no RFP was detected until 8th day; both of them continuously released more than 6 weeks. Therefore, 3D printing technology provides a precise and feasible method to fabricate a controlled-releasing drug implant with complicated architectures and this drug implant may present a new strategy for the prophylaxis and treatment of bone diseases such as combined bone infections and bone tuberculosis in the near future.

Keywords

rapid prototyping / three dimension printing technology / drug implants / bone infection / bone tuberculosis

References

[1] Kleem K. Gentamicin-PMMA-beads in Treating Bone and Soft Tissue Infections[J]. Zentralbl. Chir., 1979, 104(14): 934-942.

[2] Mendel V., Simanowski H. J. Therapy with Gentamicin-PMMA Beads, Gentamicin-collagen Sponge, and Cefazolin for Experimental Osteomyelitis due to Staphylococcus Aureus in Rats[J]. Arch. Orthop. Trauma Surg, 2005, 125(6): 363-368.

[3] Joosten U., Alexander J., Gosheger G. Effectiveness of Hydroxyapatite-vancomycin Bone Cement in the Treatment of Staphylococcus Aureus Induced Chronic Osteomyelitis[J]. Biomaterials, 2005, 26(25): 5251-5258.

[4] D Arlen, A D Hanssen. Local Antibiotic Delivery Vehicles in the Treatment of Musculoskeletal Infection[J]. Clin. Orthop. Relat. Res., 2005, (437): 91–96

[5] Gabriel T. M., David G., Scott J. Mechanical and in vivo Performance of Hydroxyapatite Implants with Controlled Architectures[J]. Biomaterials, 2002, 23(5): 1283-1293.

[6] Zheng Q. X., Guo X. D., Du J. Y. Biodegradation of Absorbable HA/dl-PLA Composites in Different Environment[J]. J. Wuhan Univ. Technol.-Mater. Sci. Ed., 2002, 17(3): 24-29.

[7] Castro C., Sanchez E., Delgado A Ciprofloxacin Implants for Bone Infection in vitro-in vivo Characterization[J]. J. Control Release, 2003, 93(3): 341-354.

[8] Jill K. S., Susan L. R., Robert P. A Three-dimensional Osteochondral Composite Scaffold for Articular Cartilage Repair[J]. Biomaterials, 2002, 23(24): 4739-4751.

[9] Hermann S., Wolfgang R., Stephan I., . Three-dimensional Printing of Porous Ceramic Scaffolds for Bone Tissue Engineering[J]. J. Biomed. Mater. Res. B. Appl. Biomater., 2005, 74(2): 782-788.

[10] Sarah L. T., Tejal A. D. Microfabricated Drug Delivery Systems: from Particles to Pores[J]. Adv. Drug Deliv. Rev., 2003, 55(3): 315-328.

[11] Wu B. M., Borland S. W., Giordano R. A., . Solid Free-form Fabrication of Drug Delivery Devices[J]. J. Control Release, 1996, 40(1–2): 77-87.

[12] Huang W. D., Sun W. Q., Zheng Q. X. Design and Fabrication of Drug Delivery Devices with Complex Architectures based on Three-dimensional Printing Technique[J]. J. Wuhan Univ. Technol.-Mater. Sci. Ed., 2005, 20(1): 80-82.

[13] Huang W. D., Zheng Q. X. Levofloxacin Implants with Predefined Microstructure Fabricated by Three-dimensional Printing Technique[J]. Int. J. Pharm., 2007, 339(1–2): 33-38.

[14] Leong K. F., Cheah C. M., Chua C. K. Solid Freeform Fabrication of Three-dimensional Scaffolds for Engineering Replacement Tissues and Organs[J]. Biomaterials, 2003, 24(13): 2363-2378.

[15] Sachols E., Reis N., Ainsley C. Novel Collagen Scaffolds with Prefined Internal Morphology Made by Solid Freeform Fabrication[J]. Biomaterials, 2003, 24(8): 1487-1497.

[16] Wang C. J., Calhoun J. H., Mader J. T. The Application of Bioimplants in the Management of Chronic Osteomyelitis[ J]. Orthopedics, 2002, 25(11): 1247-52.

[17] C G Ambrose, G R Gogola, T A Clyburn, et al. Antibiotic Microspheres: Preliminary Testing for Potential Treatment of Osteomyelitis[ J]. Clin. Orthop. Relat. Res., 2003, (415): 279–285

[18] Kanellakopoulou K., Giamarellos-Bourboulis E. J. Carrier Systems for the Local Delivery of Antibiotics in Bone Infections[ J]. Drugs, 2000, 59(6): 1223-1232.

[19] S G Hickmon, R A Skinner, C L Nelson, et al. Efficacy of Treatment of Experimental Osteomyelitis with Calcium Sulfate Pellets Containing Tobramycin[C]. The Forty-Fourth Annual Meeting of the Orthopaedic Research Society, New Orleans, LA 427, 1998

[20] Wang G. H., Liu S. J. The Release of Cefazolin and Gentamicin from Biodegradable PLA/PGA Beads[J]. Int. J. Pharm., 2004, 273(1–2): 203-212.

[21] Ruszczak Z., Friess W. Collagen as a Carrier for On-site Delivery of Antibacterial Drugs[J]. Adv. Drug Deliv. Rev., 2003, 55(12): 1679-1698.

[22] Jones J. R., Ahir S., Hench L. L. Large-scale Production of 3D Bioactive Glass Macro-porous Scaffolds for Tissue Engineering[ J]. J. Sol. Gel. Sci. Tech., 2004, 29(3): 179-188.